Category: Australia Focus
-
Advancing Human Performance: Control Bionics Showcases NeuroStrip at PEAK 2026
The intersection of sports science and technological innovation was on full display at the PEAK 2026 conference in Las Vegas. For the Control Bionics team, the event served as a premier platform to demonstrate how our latest advancements are reshaping the landscape of athletic monitoring and rehabilitation. Representing the company at our exhibit hall booth,…
-
Annette Curry joins Control Bionics as Head of Sales – Australia
Control Bionics continues to expand our leadership team with new Head of Sales – Australia, Annette Curry. Annette brings years of experience as a nurse practitioner, sales and marketing leader.
-
Speak Up Podcast: Control Bionics Discusses Voice Banking with Speech Pathology Australia
On Wednesday, Control Bionics CEO, Rob Wong, was a guest on the Speak Up Podcast, discussing voice banking for people faced with losing their ability to speak.
-
Control Bionics set to enter the ASX bourse next week; inspired by Stephen Hawking and already FDA approved
Medtech company Control Bionics (ASX:CBL) will list on the ASX next week. The company’s EMG (electromyography)-based technology helps people with disabilities inhibiting communications to do so through electronic devices that pick up their neuroelectric systems. Examples of such conditions include motor-neuron disease, cerebral palsy, and spinal cord injuries. Control Bionics’ flagship product, NeuroNode 3, is watch-sized…
-
Kristin Harley: Communicating in the ICU with NeuroNode
Kristin Harley, diagnosed with motor neurone disease in early 2013, makes the tough choice to have a tracheostomy. While she has been using the NeuroNode at home for the past several months to control text, text-to-speech, emails, and more – she now needs it as she recovers from surgery in the ICU at Macquarie University. SYDNEY, AUSTRALIA – Dec.3,…